Your browser doesn't support javascript.
loading
High accuracy of recombinant fusion protein early secretory antigenic target protein 6-culture filtrate protein 10 skin test for the detection of tuberculosis infection: a phase III, multi-centered, double-blind, hospital-based, randomized controlled trial.
Xia, Lu; Xu, Miao; Li, Feng; Li, Tao; Yang, Heng; Wang, Weihua; Wu, Qi; Li, Youlun; Chen, Xiaohong; Ou, Qinfang; Chu, Naihui; Pan, Hongqiu; Deng, Qunyi; Mei, Xiaodong; Lowrie, Douglas B; Liu, Xuhui; Wang, Guozhi; Lu, Shuihua.
Affiliation
  • Xia L; Department of tuberculosis, Shanghai Public Health Clinical Center, Fudan University, Shanghai, China.
  • Xu M; Institute for the Control of Biological Products, National Institutes for Food and Drug Control, Beijing, China.
  • Li F; Department of tuberculosis, Shanghai Public Health Clinical Center, Fudan University, Shanghai, China.
  • Li T; Department of tuberculosis, Shanghai Public Health Clinical Center, Fudan University, Shanghai, China.
  • Yang H; Department of tuberculosis, Shanghai Public Health Clinical Center, Fudan University, Shanghai, China.
  • Wang W; Department of pulmonary medicine, Wuhan Pulmonary Hospital, Wuhan, China.
  • Wu Q; Department of pulmonary medicine, Tianjin Haihe Hospital, Tianjin University, Tianjin, China.
  • Li Y; Department of pulmonary medicine, The First Affiliated Hospital of Chongqing Medical University, Chongqing, China.
  • Chen X; Department of tuberculosis, Fuzhou Pulmonary Hospital of Fujian, Fuzhou, China.
  • Ou Q; Department of pulmonary medicine, The Fifth People's Hospital of Wuxi, Wuxi, China.
  • Chu N; Department of tuberculosis, Beijing Chest Hospital Affiliated to Capital Medical University, Beijing, China.
  • Pan H; Department of pulmonary medicine, The Third People's Hospital of Zhenjiang, Zhenjiang, China.
  • Deng Q; National Clinical Research Center for Infectious Diseases, Shenzhen Third People's Hospital, Shenzhen, China.
  • Mei X; Department of pulmonary medicine, The First Affiliated Hospital of the University of Science and Technology of China (Anhui Provincial Hospital), Hefei, China.
  • Lowrie DB; National Clinical Research Center for Infectious Diseases, Shenzhen Third People's Hospital, Shenzhen, China.
  • Liu X; National Clinical Research Center for Infectious Diseases, Shenzhen Third People's Hospital, Shenzhen, China. Electronic address: liuxuhui666@126.com.
  • Wang G; Institute for the Control of Biological Products, National Institutes for Food and Drug Control, Beijing, China. Electronic address: vaccine2012@126.com.
  • Lu S; National Clinical Research Center for Infectious Diseases, Shenzhen Third People's Hospital, Shenzhen, China. Electronic address: lushuihua66@126.com.
Int J Infect Dis ; 126: 98-103, 2023 Jan.
Article in En | MEDLINE | ID: mdl-36400376
Subject(s)
Key words
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Tuberculosis / Latent Tuberculosis / Mycobacterium tuberculosis Type of study: Clinical_trials / Diagnostic_studies / Guideline Limits: Humans Language: En Journal: Int J Infect Dis Journal subject: DOENCAS TRANSMISSIVEIS Year: 2023 Document type: Article Affiliation country: China Country of publication: Canada
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Tuberculosis / Latent Tuberculosis / Mycobacterium tuberculosis Type of study: Clinical_trials / Diagnostic_studies / Guideline Limits: Humans Language: En Journal: Int J Infect Dis Journal subject: DOENCAS TRANSMISSIVEIS Year: 2023 Document type: Article Affiliation country: China Country of publication: Canada